X-70343712-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012310.5(KIF4A):​c.1276G>T​(p.Ala426Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00101 in 1,209,912 control chromosomes in the GnomAD database, including 7 homozygotes. There are 314 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A426T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0057 ( 6 hom., 176 hem., cov: 23)
Exomes 𝑓: 0.00052 ( 1 hom. 138 hem. )

Consequence

KIF4A
NM_012310.5 missense

Scores

2
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.09

Publications

1 publications found
Variant links:
Genes affected
KIF4A (HGNC:13339): (kinesin family member 4A) This gene encodes a member of the kinesin 4 subfamily of kinesin related proteins. The encoded protein is an ATP dependent microtubule-based motor protein that is involved in the intracellular transport of membranous organelles. This protein also associates with condensed chromosome arms and may be involved in maintaining chromosome integrity during mitosis. This protein may also be involved in the organization of the central spindle prior to cytokinesis. A pseudogene of this gene is found on chromosome X.[provided by RefSeq, Mar 2010]
KIF4A Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked 100
    Inheritance: Unknown, XL Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065947175).
BP6
Variant X-70343712-G-T is Benign according to our data. Variant chrX-70343712-G-T is described in ClinVar as Benign. ClinVar VariationId is 377032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00573 (642/112002) while in subpopulation AFR AF = 0.0194 (598/30859). AF 95% confidence interval is 0.0181. There are 6 homozygotes in GnomAd4. There are 176 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 Unknown,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF4ANM_012310.5 linkc.1276G>T p.Ala426Ser missense_variant Exon 12 of 31 ENST00000374403.4 NP_036442.3 O95239-1Q59HG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF4AENST00000374403.4 linkc.1276G>T p.Ala426Ser missense_variant Exon 12 of 31 1 NM_012310.5 ENSP00000363524.3 O95239-1

Frequencies

GnomAD3 genomes
AF:
0.00573
AC:
642
AN:
111951
Hom.:
6
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0194
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00303
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000375
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000751
Gnomad OTH
AF:
0.00467
GnomAD2 exomes
AF:
0.00168
AC:
307
AN:
183113
AF XY:
0.000843
show subpopulations
Gnomad AFR exome
AF:
0.0211
Gnomad AMR exome
AF:
0.000767
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000245
Gnomad OTH exome
AF:
0.00155
GnomAD4 exome
AF:
0.000524
AC:
575
AN:
1097910
Hom.:
1
Cov.:
30
AF XY:
0.000380
AC XY:
138
AN XY:
363270
show subpopulations
African (AFR)
AF:
0.0184
AC:
486
AN:
26398
American (AMR)
AF:
0.000739
AC:
26
AN:
35199
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19383
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30202
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54123
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40530
Middle Eastern (MID)
AF:
0.00145
AC:
6
AN:
4127
European-Non Finnish (NFE)
AF:
0.00000831
AC:
7
AN:
841861
Other (OTH)
AF:
0.00106
AC:
49
AN:
46087
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00573
AC:
642
AN:
112002
Hom.:
6
Cov.:
23
AF XY:
0.00515
AC XY:
176
AN XY:
34182
show subpopulations
African (AFR)
AF:
0.0194
AC:
598
AN:
30859
American (AMR)
AF:
0.00303
AC:
32
AN:
10562
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3578
South Asian (SAS)
AF:
0.000376
AC:
1
AN:
2659
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6016
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000751
AC:
4
AN:
53249
Other (OTH)
AF:
0.00461
AC:
7
AN:
1519
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00186
Hom.:
89
Bravo
AF:
0.00653
ESP6500AA
AF:
0.0235
AC:
90
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.00190
AC:
231
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 05, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

KIF4A-related disorder Benign:1
Mar 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.85
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.77
T
MetaRNN
Benign
0.0066
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
2.0
M
PhyloP100
4.1
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.092
Sift
Benign
0.11
T
Sift4G
Benign
0.22
T
Polyphen
0.079
B
Vest4
0.15
MVP
0.64
MPC
0.38
ClinPred
0.013
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.21
gMVP
0.20
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145983282; hg19: chrX-69563562; API